[HTML][HTML] COVID-19 vaccine-induced myocarditis: case report with literature review

M Nassar, N Nso, C Gonzalez, S Lakhdar… - Diabetes & metabolic …, 2021 - ncbi.nlm.nih.gov
Myocarditis is the progressive inflammation of the middle layer of the heart followed by a
myocardial injury without ischemic events [1, 2]. The infectious and non-infectious causes of …

Pericardial diseases in COVID19: a contemporary review

MM Furqan, BR Verma, PC Cremer, M Imazio… - Current Cardiology …, 2021 - Springer
Abstract Purpose of Review Coronavirus disease 2019 (COVID19) involves the heart,
including pericardium. This article reviews the possible pathophysiological mechanisms in …

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the …

CEZ Chan, SGK Seah, DH Chye, S Massey, M Torres… - PLoS …, 2021 - journals.plos.org
Although SARS-CoV-2-neutralizing antibodies are promising therapeutics against COVID-
19, little is known about their mechanism (s) of action or effective dosing windows. We report …

The association of subacute thyroiditis with COVID-19: a systematic review

M Aemaz Ur Rehman, H Farooq, MM Ali… - SN Comprehensive …, 2021 - Springer
The multisystem effects of SARS-CoV-2 encompass the thyroid gland as well. Emerging
evidence suggests that SARS-CoV-2 can act as a trigger for subacute thyroiditis (SAT). We …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-Kuraishy, AI Al-Gareeb… - Inflammation …, 2022 - Springer
Introduction Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - PloS one, 2022 - journals.plos.org
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19

C Tsagkaris, M Bilal, I Aktar, Y Aboufandi… - Current Alzheimer …, 2022 - ingentaconnect.com
The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus
(SARS-CoV-2), a respiratory pathogen with neuroinvasive potential. Neurological COVID-19 …

Cardiovascular aspects of COVID-19

DJ Kurz, FR Eberli - Swiss Medical Weekly, 2020 - smw.ch
Summary Coronavirus disease 2019 (COVID-19) is primarily a pulmonary disease, but also
affects the cardiovascular system in multiple ways. In this review, we will summarise and put …

Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review

TFD Liu, E Philippou, O Kolokotroni, G Siakallis… - Infection, 2021 - Springer
Abstract Background The SARS-CoV-2 virus is responsible for the COVID-19 pandemic.
Researchers have been studying the pathogenesis of the virus with the aim to improve our …

A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)

R Lotfi, RN Kalmarzi, SA Roghani - Immunologic research, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by a
newly identified coronavirus called the severe acute respiratory syndrome-coronavirus 2 …